INS and inflammatory bowel disease: Moreover, the lean IBD group with MASLD had higher levels of liver stiffness (kPa), increased BMI levels, increased waist-hip ratio, worse glycemic control, increased insulin resistance, and poor lipid profile outcomes compared with the lean IBD group without MASLD (Supplementary Table 3).